2nd Rare CNS and Neurodevelopmental Drug Development Summit
Boston, MADeveloping New Outcome Measures, Functional Biomarkers and Clinical Research Regulatory Frameworks for Disease-Modifying Therapeutics Across Neurodevelopmental and Rare, Genetic CNS Disorders